Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma (HCC) has a high recurrence rate after curative resection. The GAAD score, which combines gender, age, α-fetoprotein (AFP), and PIVKA-II, was developed for HCC detection, but its prognostic value after resection remains unclear. We retrospectively analyzed 294 patients who underwent curative-intent liver resection for HCC at a single center. The prognostic associations of preoperative GAAD, AFP, and PIVKA-II with recurrence-free survival (RFS) and overall survival (OS) were evaluated using Kaplan-Meier analysis and Cox regression. During a median follow-up of 86.8 months (IQR, 26.6-112.3), 168 patients (57.1%) developed recurrence and 114 (38.8%) died. GAAD ≥ 1 was associated with shorter RFS (p = 0.005) and remained independently associated with recurrence after adjustment for clinicopathological factors (HR 1.85, 95% CI 1.09-3.15; p = 0.023). This association remained significant in patients with BCLC stage 0/A. Among patients with AFP < 7 ng/mL, GAAD ≥ 1 remained independently associated with recurrence, whereas PIVKA-II ≥ 22 ng/mL did not. GAAD ≥ 1 was not associated with OS. In conclusion, GAAD ≥ 1 was independently associated with postoperative HCC recurrence but not with OS. Given its modest discrimination and cohort-derived cutoff, these exploratory findings require external validation.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: